Name | N-(1,3-benzodioxol-5-ylmethyl)-6-chloroquinazolin-4-amine |
---|---|
Synonyms |
4-((3,4-Methylenedioxybenzyl)amino)-6-chloroquinazoline
UPCMLD-DP008 MBCQ |
Description | MBCQ is a potent and selective cGMP-specific phosphodiesterase (PDE V; PDE5) inhibitor with an IC50 of 19 nM. MBCQ lacks inhibitory activity toward other PDE isozymes (all IC50s>100 μM). MBCQ dilates coronary arteries via specific inhibition of cGMP-PDE[1][2][3]. |
---|---|
Related Catalog | |
Target |
PDE V:19 nM (IC50) PDE Ⅰ:>100 μM (IC50) PDE Ⅱ:>100 μM (IC50) PDE Ⅲ:>100 μM (IC50) PDE Ⅳ:>100 μM (IC50) |
In Vitro | MBCQ (compound 3d) induces relaxation of isolated porcine coronary arteries precontracted with prostaglandin F2α (PGF2α; EC50=190 nM)[1]. MBCQ (0.01-10 μM; 10 min) inhibits Carbachol (10 μM)-induced contractions in a concentration-dependent manner in rat ileal smooth muscle[3]. |
References |
Molecular Formula | C16H12ClN3O2 |
---|---|
Molecular Weight | 313.73800 |
Exact Mass | 313.06200 |
PSA | 56.27000 |
LogP | 3.69700 |
RIDADR | NONH for all modes of transport |
---|